The frontier of peptide science is moving fast — and Global Peptide Sciences is moving with it. As well as supplying the established research staples like BPC-157, TB-500 peptide, GHK-Cu copper peptide, and Tesamorelin australia, GPS actively expands its catalogue to include emerging compounds gaining traction in longevity and metabolic research. Epithalon — a tetrapeptide studied for telomere elongation and epigenetic regulation — sits alongside MOTS-C (a mitochondria-derived peptide investigated for metabolic resilience and longevity pathways), Retatrutide (a triple agonist studied for superior weight loss and metabolic outcomes), and 5-Amino-1MQ australia (an NNMT inhibitor researched for NAD+ biosynthesis modulation). All compounds are independently tested via HPLC and LC-MS through GPS's partnership with Forever Young Analytics and dispatched from Western Australia with batch certificates of analysis. For researchers at the cutting edge, GPS is the Australian peptide supplier built to keep pace.